Guidelines for the Management of Cholestatic Liver Diseases (2021)

作     者：Lungen Lu Chinese Society of Hepatology Chinese Medical Association Lungen Lu;Chinese Society of Hepatology;Chinese Medical Association

作者机构：Department of GastroenterologyShanghai General HospitalShanghai Jiaotong University School of MedicineShanghaiChina 

出 版 物：《Journal of Clinical and Translational Hepatology》 (临床与转化肝病杂志（英文版）)

年 卷 期：2022年第10卷第4期

页      面：757-769页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Cholestatic liver disease Diagnosis Therapeutics Practice guidelines 

摘      要：In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology issued a consensus statement on the diagnosis and management of cholestatic liver diseases. More clinical data on this topic have appeared during recent years. The Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review recent evidence and provide an update to these previous guidelines. Herein, we provide 22 recommendations as a working reference for the management of cholestatic liver diseases by clinical practitioners.